|
1.
|
L MirabelloRJ TroisiSA SavageOsteosarcoma
incidence and survival rates from 1973 to 2004: data from the
Surveillance, Epidemiology, and End Results
ProgramCancer11515311543200910.1002/cncr.2412119197972
|
|
2.
|
VO LewisWhat’s new in musculoskeletal
oncologyJ Bone Joint Surg Am91154615562009
|
|
3.
|
PA MeyersCL SchwartzM KrailoOsteosarcoma:
a randomized, prospective trial of the addition of ifosfamide
and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose
methotrexateJ Clin
Oncol2320042011200510.1200/JCO.2005.06.03115774791
|
|
4.
|
Y ChoGH JungSH ChungJY KimY ChoiJD
KimLong-term survivals of stage IIb osteosarcoma: a 20-year
experience in a single institutionClin Orthop
Surg34854201121369478
|
|
5.
|
H TsuchiyaK TomitaY MoriCaffeine-assisted
chemotherapy and minimized tumor excision for nonmetastatic
osteosarcomaAnticancer Res1865766619989584049
|
|
6.
|
T BollingP SchullerB
DistelmaierPerioperative high-dose rate brachytherapy using a bendy
applicator (flab): treatment results of 74 patientsAnticancer
Res2838853890200819192645
|
|
7.
|
N MarinaM GebhardtL TeotR GorlickBiology
and therapeutic advances for pediatric
osteosarcomaOncologist9422441200410.1634/theoncologist.9-4-42215266096
|
|
8.
|
T WadaK IsuN TakedaM UsuiS IshiiS
YamawakiA preliminary report of neoadjuvant chemotherapy NSH-7
study in osteosarcoma: preoperative salvage chemotherapy based on
clinical tumor response and the use of granulocyte
colony-stimulating factorOncology53221227199610.1159/000227564
|
|
9.
|
CS YehJY WangTL ChengCH JuanCH WuSR
LinFatty acid metabolism pathway play an important role in
carcinogenesis of human colorectal cancers by
Microarray-Bioinformatics analysisCancer
Lett233297308200610.1016/j.canlet.2005.03.05015885896
|
|
10.
|
D HessRA IgalGenistein downregulates de
novo lipid synthesis and impairs cell proliferation in human lung
cancer cellsExp Biol Med
(Maywood)236707713201110.1258/ebm.2011.01026521565896
|
|
11.
|
PL AloM AminiF PiroImmunohistochemical
expression and prognostic significance of fatty acid synthase in
pancreatic carcinomaAnticancer Res2725232527200717695548
|
|
12.
|
K WalterSM HongS NyhanSerum fatty acid
synthase as a marker of pancreatic neoplasiaCancer Epidemiol
Biomarkers
Prev1823802385200910.1158/1055-9965.EPI-09-014419723916
|
|
13.
|
Y OkawaT HideshimaH IkedaFatty acid
synthase is a novel therapeutic target in multiple myelomaBr J
Haematol141659671200810.1111/j.1365-2141.2008.07114.x
|
|
14.
|
T MigitaS RuizA FornariFatty acid
synthase: a metabolic enzyme and candidate oncogene in prostate
cancerJ Natl Cancer
Inst101519532200910.1093/jnci/djp03019318631
|
|
15.
|
H OritaJ CoulterE TullyFP KuhajdaE
GabrielsonInhibiting fatty acid synthase for chemoprevention of
chemically induced lung tumorsClin Cancer
Res1424582464200810.1158/1078-0432.CCR-07-417718413838
|
|
16.
|
DT ColemanR BigelowJA CardelliInhibition
of fatty acid synthase by luteolin post-transcriptionally
down-regulates c-Met expression independent of
proteosomal/lysosomal degradationMol Cancer
Ther8214224200910.1158/1535-7163.MCT-08-072219139131
|
|
17.
|
GE SaatiMC ArcherInhibition of fatty acid
synthase and Sp1 expression by 3,3′-diindolylmethane in human
breast cancer cellsNutr Cancer637907942011
|
|
18.
|
M NotarnicolaS PisantiV TutinoEffects of
olive oil polyphenols on fatty acid synthase gene expression and
activity in human colorectal cancer cellsGenes
Nutr66369201110.1007/s12263-010-0177-721437031
|
|
19.
|
M NotarnicolaC MessaMG RefoloV TutinoA
MiccolisMG CarusoPolyunsaturated fatty acids reduce fatty acid
synthase and hydroxy-methyl-glutaryl CoA-reductase gene expression
and promote apoptosis in HepG2 cell lineLipids Health
Dis1010201110.1186/1476-511X-10-1021244676
|
|
20.
|
KG ZecchinFA RossatoHF RaposoInhibition of
fatty acid synthase in melanoma cells activates the intrinsic
pathway of apoptosisLab
Invest91232240201110.1038/labinvest.2010.15720805790
|
|
21.
|
MA CarvalhoKG ZecchinF SeguinFatty acid
synthase inhibition with Orlistat promotes apoptosis and reduces
cell growth and lymph node metastasis in a mouse melanoma modelInt
J Cancer12325572565200810.1002/ijc.2383518770866
|
|
22.
|
S MurataK YanagisawaK FukunagaFatty acid
synthase inhibitor cerulenin suppresses liver metastasis of colon
cancer in miceCancer
Sci10118611865201010.1111/j.1349-7006.2010.01596.x20491775
|
|
23.
|
VN KimJ HanMC SiomiBiogenesis of small
RNAs in animalsNat Rev Mol Cell
Biol10126139200910.1038/nrm263219165215
|
|
24.
|
DP BartelMicroRNAs: target recognition and
regulatory
functionsCell136215233200910.1016/j.cell.2009.01.00219167326
|
|
25.
|
MA Valencia-SanchezJ LiuGJ HannonR
ParkerControl of translation and mRNA degradation by miRNAs and
siRNAsGenes Dev20515524200610.1101/gad.139980616510870
|
|
26.
|
GA CalinC SevignaniCD DumitruHuman
microRNA genes are frequently located at fragile sites and genomic
regions involved in cancersProc Natl Acad Sci
USA10129993004200410.1073/pnas.030732310114973191
|
|
27.
|
X WangJ WangH MaJ ZhangX
ZhouDownregulation of miR-195 correlates with lymph node metastasis
and poor prognosis in colorectal cancerMed Oncol201121390519
|
|
28.
|
X BaiD MaA LiuRheb activates mTOR by
antagonizing its endogenous inhibitor,
FKBP38Science318977980200710.1126/science.114737917991864
|
|
29.
|
T XuY ZhuY XiongYY GeJP YunSM
ZhuangMicroRNA-195 suppresses tumorigenicity and regulates G1/S
transition of human hepatocellular carcinoma
cellsHepatology50113121200910.1002/hep.2291919441017
|
|
30.
|
PS SoonLJ TaconAJ GillmiR-195 and
miR-483-5p identified as predictors of poor prognosis in
adrenocortical cancerClin Cancer
Res1576847692200910.1158/1078-0432.CCR-09-158719996210
|
|
31.
|
TS WongXB LiuBY WongRW NgAP YuenWI
WeiMature miR-184 as potential oncogenic microRNA of squamous cell
carcinoma of tongueClin Cancer
Res1425882592200810.1158/1078-0432.CCR-07-066618451220
|
|
32.
|
L LiuL ChenY XuR LiX DumicroRNA-195
promotes apoptosis and suppresses tumorigenicity of human
colorectal cancer cellsBiochem Biophys Res
Commun400236240201010.1016/j.bbrc.2010.08.04620727858
|
|
33.
|
D LiY ZhaoC LiuAnalysis of MiR-195 and
MiR-497 expression, regulation and role in breast cancerClin Cancer
Res1717221730201110.1158/1078-0432.CCR-10-180021350001
|
|
34.
|
B BrennerMB HoshenO PurimMicroRNAs as a
potential prognostic factor in gastric cancerWorld J
Gastroenterol1739763985201110.3748/wjg.v17.i35.397622046085
|
|
35.
|
HM HeneghanN MillerR KellyJ NewellMJ
KerinSystemic miR-195 differentiates breast cancer from other
malignancies and is a potential biomarker for detecting noninvasive
and early stage
diseaseOncologist15673682201010.1634/theoncologist.2010-010320576643
|
|
36.
|
HM HeneghanN MillerAJ LoweryKJ SweeneyJ
NewellMJ KerinCirculating microRNAs as novel minimally invasive
biomarkers for breast cancerAnn
Surg251499505201010.1097/SLA.0b013e3181cc939f20134314
|
|
37.
|
BN HannafonP SebastianiA de las MorenasJ
LuCL RosenbergExpression of microRNA and their gene targets are
dysregulated in preinvasive breast cancerBreast Cancer
Res13R24201110.1186/bcr283921375733
|
|
38.
|
H ZhangSB SuQM ZhouYY LuDifferential
expression profiles of microRNAs between breast cancer cells and
mammary epithelial cellsAi Zheng28493499200919624877
|
|
39.
|
DL ZanetteF RivadaviaGA MolfettamiRNA
expression profiles in chronic lymphocytic and acute lymphocytic
leukemiaBraz J Med Biol
Res4014351440200710.1590/S0100-879X200700110000317934639
|
|
40.
|
WY WuXY XueZJ ChenPotentially predictive
microRNAs of gastric cancer with metastasis to lymph nodeWorld J
Gastroenterol1736453651201110.3748/wjg.v17.i31.364521987613
|
|
41.
|
M SelbachB SchwanhausserN ThierfelderZ
FangR KhaninN RajewskyWidespread changes in protein synthesis
induced by
microRNAsNature4555863200810.1038/nature0722818668040
|
